Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation

HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K Quarterly results
08/16/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "CORRECTED CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HELIUS MEDICAL TECHNOLOGIES, INC. Helius Medical Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware , certifies that: 1.            The Certificate of Amendment to the Certificate of Incorporation that was filed with the Delaware Secretary of State on August 15, 2023 requires correction as permitted by Section 103 of the Delaware General Corporation Law. 2.            The defect in such Certificate of Amendment to the Certificate of Incorporation is as follows: The Certificate of Amendment to the Certificate of Incorporation shall...",
"Lisa M. Wilson, In-Site Communications, Inc."
08/10/2023 8-K Quarterly results
05/11/2023 8-K Quarterly results
03/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications t...
03/09/2023 8-K Quarterly results
01/23/2023 8-K Investor presentation
11/14/2022 8-K Quarterly results
09/30/2022 8-K Quarterly results
09/23/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/15/2022 8-K Quarterly results
08/09/2022 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Form of Warrant to purchase shares of common stock",
"Warrant Agency Agreement by and between Helius Medical Technologies, Inc. and American Stock Transfer & Trust Company, LLC",
"Form of Pre-Funded Warrant to purchase shares of common stock",
"Form of Securities Purchase Agreement by and between Helius Medical Technologies, Inc. and the purchasers named therein",
"Placement Agency Agreement by and between Helius Medical Technologies, Inc. and Roth Capital Partners, LLC",
"Company Press Release"
05/27/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
04/27/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "NEWTOWN, Pa., April 27, 2022"
04/01/2022 8-K Investor presentation
Docs: "Corporate Presentation, dated April 2022"
03/14/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results"
03/11/2022 8-K Quarterly results
02/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Helius Medical Technologies, Inc. 2022 Equity Incentive Plan",
"Helius Medical Technologies, Inc. 2022 Equity Incentive Plan Form of Option Grant Agreement"
01/26/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Helius Medical Technologies, Inc. Provides Corporate Update"
11/29/2021 8-K Investor presentation
Docs: "Corporate Presentation, dated November 2021"
11/12/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and between Helius Medical Technologies, Inc. and Ladenburg Thalmann & Co. Inc",
"Opinion of Honigman LLP",
"Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock",
"Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock"
11/10/2021 8-K Quarterly results
Docs: "Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results"
11/04/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Helius Medical Technologies, Inc. Receives PoNS ® Market Authorization in Australia"
09/17/2021 8-K Quarterly results
09/14/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors"
09/02/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"PURCHASE AGREEMENT PURCHASE AGREEMENT , dated as of September 1, 2021, by and between HELIUS MEDICAL TECHNOLOGIES, INC., a Delaware corporation , and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company . WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wishes to buy from the Company, up to Fifteen Million Dollars of the Company's Class A common stock, $0.001 par value per share . The shares of Common Stock to be purchased hereunder are referred to herein as the “ Purchase Shares .” NOW THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and th...",
"REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT , dated as of September 1, 2021, by and between HELIUS MEDICAL TECHNOLOGIES, INC., a Delaware corporation , and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company . Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Purchase Agreement by and between the parties hereto, dated as of the date hereof . WHEREAS: A. Upon the terms and subject to the conditions of the Purchase Agreement, the Company has agreed to issue to the Investor, and the Investor has agreed to purchase, up to Fifteen Million Dollars of the Company's Class A common stock, par value $0.001 per share , pursuant to the Purchase Agreement , and the Company has agreed to issue to ..."
08/25/2021 8-K Quarterly results
08/24/2021 8-K Quarterly results
08/19/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation and Release Agreement between Helius Medical Technologies, Inc. and Joyce LaViscount"
08/17/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke"
08/12/2021 8-K Quarterly results
Docs: "Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results"
07/26/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/13/2021 8-K Investor presentation
Docs: "Corporate Presentation, dated July 2021"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy